Terms: = Leukemia AND ERG, P11308, 2078 AND Clinical Outcome
12 results:
1. Analysis of rare driving events in pediatric acute myeloid leukemia.
Noort S; Oosterwijk JV; Ma J; Garfinkle EAR; Nance S; Walsh M; Song G; Reinhardt D; Pigazzi M; Locatelli F; Hasle H; Abrahamsson J; Jarosova M; Kelaidi C; Polychronopoulou S; Van den Heuvel-Eibrink MM; Fornerod M; Gruber TA; Zwaan CM
Haematologica; 2023 Jan; 108(1):48-60. PubMed ID: 35899387
[TBL] [Abstract] [Full Text] [Related]
2. Steroid receptor-associated and regulated protein is a biomarker in predicting the clinical outcome and treatment response in malignancies.
Naderi A
Cancer Rep (Hoboken); 2020 Oct; 3(5):e1267. PubMed ID: 32706923
[TBL] [Abstract] [Full Text] [Related]
3. Overexpression of erg in cord blood progenitors promotes expansion and recapitulates molecular signatures of high erg leukemias.
Tursky ML; Beck D; Thoms JA; Huang Y; Kumari A; Unnikrishnan A; Knezevic K; Evans K; Richards LA; Lee E; Morris J; Goldberg L; Izraeli S; Wong JW; Olivier J; Lock RB; MacKenzie KL; Pimanda JE
Leukemia; 2015 Apr; 29(4):819-27. PubMed ID: 25306899
[TBL] [Abstract] [Full Text] [Related]
4. Activity of a heptad of transcription factors is associated with stem cell programs and clinical outcome in acute myeloid leukemia.
Diffner E; Beck D; Gudgin E; Thoms JA; Knezevic K; Pridans C; Foster S; Goode D; Lim WK; Boelen L; Metzeler KH; Micklem G; Bohlander SK; Buske C; Burnett A; Ottersbach K; Vassiliou GS; Olivier J; Wong JW; Göttgens B; Huntly BJ; Pimanda JE
Blood; 2013 Mar; 121(12):2289-300. PubMed ID: 23327922
[TBL] [Abstract] [Full Text] [Related]
5. Micro-RNAs and copy number changes: new levels of gene regulation in acute myeloid leukemia.
Larson RA
Chem Biol Interact; 2010 Mar; 184(1-2):21-5. PubMed ID: 19822134
[TBL] [Abstract] [Full Text] [Related]
6. BAALC and erg expression in acute myeloid leukemia with normal karyotype: impact on prognosis.
Eid MA; Attia M; Abdou S; El-Shazly SF; Elahwal L; Farrag W; Mahmoud L
Int J Lab Hematol; 2010 Apr; 32(2):197-205. PubMed ID: 19555438
[TBL] [Abstract] [Full Text] [Related]
7. Genes predictive of outcome and novel molecular classification schemes in adult acute myeloid leukemia.
Verhaak RG; Valk PJ
Cancer Treat Res; 2010; 145():67-83. PubMed ID: 20306246
[TBL] [Abstract] [Full Text] [Related]
8. The challenge of risk stratification in acute myeloid leukemia with normal karyotype.
Zaidi SZ; Owaidah T; Al Sharif F; Ahmed SY; Chaudhri N; Aljurf M
Hematol Oncol Stem Cell Ther; 2008; 1(3):141-58. PubMed ID: 20063545
[TBL] [Abstract] [Full Text] [Related]
9. clinical outcome of de novo acute myeloid leukaemia patients with normal cytogenetics is affected by molecular genetic alterations: a concise review.
Baldus CD; Mrózek K; Marcucci G; Bloomfield CD
Br J Haematol; 2007 Jun; 137(5):387-400. PubMed ID: 17488484
[TBL] [Abstract] [Full Text] [Related]
10. [TMPRSS2-ETS gene fusion in prostate cancer].
Perner S; Schmidt FH; Hofer MD; Kuefer R; Rubin M
Urologe A; 2007 Jul; 46(7):754-60. PubMed ID: 17458530
[TBL] [Abstract] [Full Text] [Related]
11. Influence of new molecular prognostic markers in patients with karyotypically normal acute myeloid leukemia: recent advances.
Mrózek K; Döhner H; Bloomfield CD
Curr Opin Hematol; 2007 Mar; 14(2):106-14. PubMed ID: 17255787
[TBL] [Abstract] [Full Text] [Related]
12. Overexpression of the ETS-related gene, erg, predicts a worse outcome in acute myeloid leukemia with normal karyotype: a Cancer and leukemia Group B study.
Marcucci G; Baldus CD; Ruppert AS; Radmacher MD; Mrózek K; Whitman SP; Kolitz JE; Edwards CG; Vardiman JW; Powell BL; Baer MR; Moore JO; Perrotti D; Caligiuri MA; Carroll AJ; Larson RA; de la Chapelle A; Bloomfield CD
J Clin Oncol; 2005 Dec; 23(36):9234-42. PubMed ID: 16275934
[TBL] [Abstract] [Full Text] [Related]